Tranaxemic acid
Based on CRASH2 trial results.
Indications
- Significant haemorrhage and SBP <90mmHg or HR >110bpm.
- At risk of significant haemorrhage.
Relative Contraindication
- History of thromboembolic disease.
- >3 hours from injury unless hyperfibrinolysis is demonstrated on ROTEM.
Administer 1g bolus over 10 minutes followed by 1g infusion over 8 hours.
The infusion can be omitted/stopped in the following patients:
- No evidence of haemorrhage, or
- Haemorrhage controlled with a normal ROTEM.